EMA and ECDC recommendations on heterologous vaccination courses against COVID-19, European Medicines Agency

The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) continue to urge all EU citizens to get fully vaccinated and to adhere to recent recommendations on booster vaccination. Currently available evidence consistently points towards acceptable tolerability and enhanced immune responses with sequential heterologous vaccination vs homologous vaccination. Clinical considerations for heterologous booster vaccine schedules are provided.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news